SYRE
#1066
Spyre Therapeutics, Inc. - Common Stock
80.4 5 USD
-0.06%
Precio de mercado
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.34%
Variación mensual
-11.42%
Variación en los últimos 6 meses
+18.75%
Cambio anual
+236.47%
Cierres anteriores
85.9 0
Apertura
85.1 3
Mínimo
80.4 5
Máximo
85.3 2
Indicadores financieros
2017
Current report, 18 Jul 2017
Spyre Therapeutics, Inc. current report, 18 July 2017
8-K
Quarterly report, Q2 FY2017
Spyre Therapeutics, Inc. quarterly report, Q2 FY2017
10-Q
Current report, 07 Jun 2017
Spyre Therapeutics, Inc. current report, 07 June 2017
8-K
Current report, 06 Jun 2017
Spyre Therapeutics, Inc. current report, 06 June 2017
8-K
Current report, 09 May 2017
Spyre Therapeutics, Inc. current report, 09 May 2017
8-K
Current report, 21 Apr 2017
Spyre Therapeutics, Inc. current report, 21 April 2017
8-K
Quarterly report, Q1 FY2017
Spyre Therapeutics, Inc. quarterly report, Q1 FY2017
10-Q
Current report, 24 Mar 2017
Spyre Therapeutics, Inc. current report, 24 March 2017
8-K
Current report, 23 Mar 2017
Spyre Therapeutics, Inc. current report, 23 March 2017
8-K
Current report, 23 Mar 2017
Spyre Therapeutics, Inc. current report, 23 March 2017
8-K